business
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)
Key takeaways
- Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM) Fatima Gulzar Mon, June 29, 2026 at 3:07 AM GMT+7 1 min read INSM Insmed Incorporated (NASDAQ:INSM) is among the Best Healthcare Stocks.
- On June 15, Mizuho lowered its price target on Insmed Incorporated (NASDAQ:INSM) to $192 from $202.
- Mizuho found the sharp move in investor sentiment "shocking" and expressed confidence in both Insmed and BRINSUPRI.
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM) Fatima Gulzar Mon, June 29, 2026 at 3:07 AM GMT+7 1 min read INSM Insmed Incorporated (NASDAQ:INSM) is among the Best Healthcare Stocks.
On June 15, Mizuho lowered its price target on Insmed Incorporated (NASDAQ:INSM) to $192 from $202. It maintained an Outperform rating on the shares. The firm stated the recent selloff created a buying opportunity even though shares have fallen 29% since the company's first-quarter report.
Mizuho found the sharp move in investor sentiment "shocking" and expressed confidence in both Insmed and BRINSUPRI.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
S&P affirms U.S. sovereign rating at AA+, maintains stable outlook
Investing.com
Mizuho reiterates Outperform on Darden stock, keeps $235 target
Investing.com
Citizens reiterates nCino stock rating at outperform, $23 target
Investing.com
RBC Capital initiates Honeywell Aerospace stock with outperform rating
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop